Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI

Magnetic Resonance Imaging

Volumn 31, Issue 1, 2013, Pages 23-27

  Yoshimura, Nobutaka ^a   Saito, Kazuhiro ^a   Saguchi, Toru ^a   Funatsu, Tomokazu ^a   Araki, Yoichi ^a   Akata, Soichi ^a   Tokuuye, Koichi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Gd EOB DTPA; Hemangioma; Liver; Metastasis; T1 map; T1 value

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; CONTRAST ENHANCEMENT RATIO; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LIVER HEMANGIOMA; LIVER METASTASIS; LONGITUDINAL RELAXATION RATE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; T1 MAPPING;

ADULT; AGED; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84870325762     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2012.06.026     Document Type: Article

References (23)

1. Hamm B., Staks T., Muhler A. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995, 195:785-792.
2. Ohtomo K., Itai Y., Yoshikawa K., Kokubo T., Yashiro N., Iio M., et al. Hepatic tumors: dynamic MR imaging. Radiology 1987, 163:27-31.
3. Semelka R.C., Brown E.D., Ascher S.M., Patt R.H., Bagley A.S., Li W., et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994, 192:401-406.
4. Li K.C., Glazer G.M., Quint L.E., Francis I.R., Aisen A.M., Ensminger W.D., et al. Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging. Radiology 1988, 169:409-415.
5. Zech C.J., Herrmann K.A., Reiser M.F., Schoenberg S.O. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007, 6:43-52.
6. Zech C.J., Grazioli L., Jonas E., Ekman M., Niebecker R., Gschwend S., et al. Health-economic evaluation of three imaging strategies in patients with suspected colorectal liver metastases: Gd-EOB-DTPA-enhanced MRI vs. extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany, Italy and Sweden. Eur Radiol 2009, 19(Suppl 3):S753-S763.
7. Gowland P., Mansfield P., Bullock P., Stehling M., Worthington B., Firth J. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging. Magn Reson Med 1992, 26:241-258.
8. Whitney W.S., Herfkens R.J., Jeffrey R.B., McDonnell C.H., Li K.C., Van Dalsem W.J., et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology 1993, 189:863-870.
9. Yamashita Y., Ogata I., Urata J., Takahashi M. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 1997, 203:121-125.
10. Freeny P.C., Marks W.M. Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT. Radiology 1986, 160:613-618.
11. Wang H.Z., Riederer S.J., Lee J.N. Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med 1987, 5:399-416.
12. de Bazelaire C.M., Duhamel G.D., Rofsky N.M., Alsop D.C. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004, 230:652-659.
13. Kim T., Murakami T., Takahashi S., Hori M., Tsuda K., Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999, 173:393-398.
14. Powers C., Ros P.R., Stoupis C., Johnson W.K., Segel K.H. Primary liver neoplasms: MR imaging with pathologic correlation. Radiographics 1994, 14:459-482.
15. Namimoto T., Yamashita Y., Sumi S., Tang Y., Takahashi M. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997, 204:739-744.
16. Ichikawa T., Haradome H., Hachiya J., Nitatori T., Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998, 170:397-402.
17. Bewick V., Cheek L., Ball J. Statistics review 13: receiver operating characteristic curves. Crit Care 2004, 8:508-512.
18. Goshima S., Kanematsu M., Watanabe H., Kondo H., Shiratori Y., Onozuka M., et al. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. AJR Am J Roentgenol 2010, 195:941-946.
19. Deoni S.C., Rutt B.K., Peters T.M. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 2003, 49:515-526.
20. Shimada K., Isoda H., Hirokawa Y., Arizono S., Shibata T., Togashi K. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 2010, 20:2690-2698.
21. Motosugi U., Ichikawa T., Onohara K., Sou H., Sano K., Muhi A., et al. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging. Invest Radiol 2011, 46:359-365.
22. Tanimoto A., Lee J.M., Murakami T., Huppertz A., Kudo M., Grazioli L. Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 2009, 19(Suppl 5):S975-S989.
23. Mamisch T.C., Dudda M., Hughes T., Burstein D., Kim Y.J. Comparison of delayed gadolinium enhanced MRI of cartilage (dGEMRIC) using inversion recovery and fast T1 mapping sequences. Magn Reson Med 2008, 60:768-773.